Atopic Dermatitis

March 14th 2025

Matthew Zirwas, MD, addresses the significant financial burden associated with the medication, emphasizing the importance of pharmacists in navigating prior authorizations and access patient support programs.

March 6th 2025

Efficacy and tolerability of topical treatments can vary by region, particularly sensitive areas such as the face and neck.

February 27th 2025

At week 8, significantly more children, adolescents, and adults who applied 1.5% ruxolitinib cream versus vehicle achieved IGA treatment success.

February 19th 2025

Embedding a pharmacist in the dermatology clinic improved clinical and financial outcomes.